EVALUATION OF MARKETED KITS FOR MEASUREMENT OF ABP 501, THE FIRST APPROVED ADALIMUMAB BIOSIMILAR, DRUG CONCENTRATION AND ANTI-DRUG ANTIBODY LEVELS IN PATIENT SERUM

被引：0
作者：
Mytych, Dan [1 ]
Manning, Marta Starcevic [1 ]
Colbert, Alexander [1 ]
Hoofring, Sarah [1 ]
Miller, Jill [1 ]
Gessner, Melissa [1 ]
Chow, Vincent [1 ]
Fanjiang, Gary [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6361
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0645
引用
收藏
页码：1020 / 1020
页数：1
相关论文
共 49 条
  • [11] Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels
    Ogric, Manca
    Zigon, Polona
    Drobne, David
    Stabuc, Borut
    Sodin-Semrl, Snezna
    Cucnik, Sasa
    Praprotnik, Sonja
    [J]. IMMUNOLOGIC RESEARCH, 2018, 66 (06) : 726 - 736
  • [12] Preventing Crohn's Disease recurrence after resection with adalimumab: Role of drug and anti-drug antibody levels
    Wright, E.
    Kamm, M.
    Selvaraj, F.
    Princen, F.
    De Cruz, P.
    Hamilton, A.
    Ritchie, K.
    Krejany, E.
    Gorelik, A.
    Liew, D.
    Prideaux, L.
    Lawrance, I.
    Andrews, J.
    Bampton, P.
    Jakobovits, S.
    Florin, T.
    Gibson, P.
    Debinski, H.
    Gearry, R.
    Macrae, F.
    Samuel, D.
    Kronborg, I.
    Radford-Smith, G.
    Selby, W.
    Johnston, M.
    Woods, R.
    Elliott, P. R.
    Bell, S.
    Brown, S.
    Connell, W.
    Desmond, P.
    Singh, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S373 - S373
  • [13] Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels
    Wright, Emily K.
    Kamm, Michael A.
    Selvaraj, Fabiyola
    Princen, Fred
    De Cruz, Peter
    Hamilton, Amy L.
    Ritchie, Kathryn
    Krejany, Efrosinia O.
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Jakobovits, Simon
    Florin, Tim
    Gibson, Peter R.
    Debinski, Henry
    Gearry, Richard B.
    Macrae, Finlay A.
    Samuel, Douglas
    Kronborg, Ian
    Radford-Smith, Graham L.
    Selby, Warwick
    Johnston, Michael J.
    Woods, Rodney
    Elliott, Peter R.
    Bell, Sally
    Brown, Steven J.
    Connell, William
    Desmond, Paul V.
    Singh, Sharat
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S849 - S849
  • [14] Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studies
    Lemke, Lena
    Blauvelt, Andrew
    Brueckmann, Ines
    Cohen, Hillel P.
    Fan, Jamie
    Guerrieri, Davide
    Horvat, Matej
    Poetzl, Johann
    Torella, Claudia
    Wang, Qingfeng
    von Richter, Oliver
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (12) : 1375 - 1385
  • [15] Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
    Jyssum, Ingrid
    Gehin, Johanna E.
    Sexton, Joseph
    Kristianslund, Eirik Klami
    Hu, Yi
    Warren, David John
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Syversen, Silje Watterdal
    Bolstad, Nils
    Goll, Guro Lovik
    [J]. RHEUMATOLOGY, 2024, 63 (06) : 1746 - 1755
  • [16] The Relationship Between Serum Infliximab and Adalimumab Concentrations and Their Corresponding Anti-drug Antibody Levels: Analysis of over 50,000 Patient Results
    Chun, Kelly Y.
    Yang, Jane M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S385 - S386
  • [17] Infliximab Assay Used in Clinical Practice Validated for Measuring SB2 Infliximab Biosimilar's Serum Drug and Anti-drug Antibody Levels
    Noguier, Guillaume
    Daviere, Simon
    Elouardani, Samia
    Veldet, Can
    Ticaud, Thierry
    Parussini, Ermis
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S398 - S398
  • [18] Clinical Outcome of Pediatric IBD Patients After Measurement of Infliximab Drug and Anti-Drug Antibody Levels
    Turon, Joanna
    Langseder, Annette
    Irizarry, Ruth
    Ahuja, Komal
    Rosh, Joel R.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S531 - S531
  • [19] Analysis of Serum Vedolizumab Concentrations in Over 800 Patient Samples: Distribution of Drug and Anti-Drug Ab Levels and Serial Measurement Trends
    Chun, Kelly Y.
    Chun, Jane
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S416 - S416
  • [20] Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical Laboratory
    Keating, Paula Elizabeth
    Hock, Barry D.
    Chin, Paul K. L.
    O'Donnell, John Liston
    Barclay, Murray Lindsay
    [J]. THERAPEUTIC DRUG MONITORING, 2024, 46 (05) : 619 - 626
12345